Literature DB >> 16173530

"Tien-Hsien liquid" can modulate antigen-stimulated cytokine production by T-cells isolated from patients with recurrent aphthous ulcerations.

Andy Sun1, Jean-San Chia, Won-Bo Wang, Chun-Pin Chiang.   

Abstract

Recurrent aphthous ulcerations (RAU) represent a common oral mucosal disease with altered humoral and cellular immunities. Tien-Hsien liquid (THL) is an extract of Chinese medicinal herbs with immunomodulating effects. Our previous study found that THL can modulate the antigen-stimulated proliferative response of peripheral blood mononuclear cells and T-cells isolated from RAU patients. In this study, we further tested whether THL can modulate the antigen-stimulated cytokine production by T-cells isolated from RAU patients. To achieve this goal, T-cells isolated from 19 RAU patients were incubated with phytohemagglutinin (PHA), glutaraldehyde-inactivated tetanus toxoid (TT), glucosyltransferase D (GtfD), or antigens of Streptococcus mutans in the presence or absence of THL. The levels of interleukin (IL)-2, interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), IL-6, or IL-10 in the supernatants of T-cell cultures were measured by cytokine enzyme-linked immunosorbent assay (ELISA) kits. We found that THL significantly increased the PHA- or TT-stimulated TNF-alpha, IL-6, and IL-10 production by T-cells isolated from RAU patients. However, THL could also significantly decrease the TT-stimulated IL-2 production, the GtfD-stimulated IL-2, TNF-alpha, IL-6 and IL-10 production, and the S. mutans-stimulated IFN-gamma, TNF-alpha, and IL-10 production by T-cells isolated from RAU patients. These results indicate that THL can modulate the antigen-stimulated cytokine production by T-cells isolated from RAU patients. Because RAU is probably a Thl-mediated disease with elevated levels of IL-2, IFN-gamma, TNF-alpha and IL-6 in either the patient's sera or oral lesions and these increased levels of cytokines can be reduced by THL, we suggest that THL may be a potential immunoceutical agent for treatment of RAU.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173530     DOI: 10.1142/S0192415X05003168

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  6 in total

1.  Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Authors:  Jean-San Chia; Jia-Ling Du; Wei-Bin Hsu; Andy Sun; Chun-Pin Chiang; Won-Bo Wang
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

2.  The traditional Chinese herbal remedy tian xian activates pregnane X receptor and induces CYP3A gene expression in hepatocytes.

Authors:  Kristin Lichti-Kaiser; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

3.  Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial.

Authors:  Wen-Hung Kuo; Chien-An Yao; Chih Hui Lin; King-Jen Chang
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-01       Impact factor: 2.629

4.  Detection of salivary interleukin-2 in recurrent aphthous stomatitis.

Authors:  R Kalpana; M Thubashini; B Sivapatha Sundharam
Journal:  J Oral Maxillofac Pathol       Date:  2014 Sep-Dec

5.  Elimination of cancer stem-like "side population" cells in hepatoma cell lines by chinese herbal mixture "tien-hsien liquid".

Authors:  Chih-Jung Yao; Chi-Tai Yeh; Liang-Ming Lee; Shuang-En Chuang; Chuan-Feng Yeh; Wan-Ju Chao; Tung-Yuan Lai; Gi-Ming Lai
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-14       Impact factor: 2.629

6.  The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell-Vaccinated Mice.

Authors:  Pei-Ming Yang; Jia-Ling Du; George Nian-Kae Wang; Jean-San Chia; Wei-Bin Hsu; Pin-Ching Pu; Andy Sun; Chun-Pin Chiang; Won-Bo Wang
Journal:  Integr Cancer Ther       Date:  2016-06-01       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.